MedTrace Logo

Trial of Adjunctive Vitamin D in Tuberculosis Treatment

NCT00419068 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2009-09-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether vitamin D enhances response to standard antibiotic treatment for pulmonary tuberculosis.

Conditions

  • Tuberculosis, Pulmonary

Interventions

DRUG

Cholecalciferol

DRUG

Migliol Placebo Oil

Sponsors & Collaborators

  • British Lung Foundation

    collaborator OTHER

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Adrian R Martineau, MRCP · Queen Mary University of London

  • Christopher J Griffiths, FRCP FRCGP D Phil · Queen Mary University of London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00419068 on ClinicalTrials.gov